Product / Gastrointestinal & Hepatobiliary System / Antiemetics / DOMPERIDONE - Suspension

DOMPERIDONE - Suspension

Group

Prescription Drug

Composition

Each 5 ml of Suspension contains: Domperidone 5mg

Packaging

Bottle 60 ML

Registration No.

GKL 1134010233A1

Indication

Adults:
*For acute nausea

*For nausea and vomiting caused by administration of levodopa and bromocriptine for more than 12 weeks
For the treatment of functional dyspepsia symptoms, not recommended for long-term administration
Children: Not recommended, except for vomiting in cancer chemotherapy and radiotherapy

Dose

Functional dyspepsia: Adults and the elderly: 10 - 20 mg 3 times a day for 12 weeks.
Children: not recommended
Nausea and vomiting (including those caused by levodopa and bromocriptine)
Adults and the elderly: 10 - 20 mg 3 times a day for 12 weeks.